Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Current Assets (2016 - 2025)

AC Immune (ACIU) has disclosed Current Assets for 10 consecutive years, with $121.0 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 38.36% to $121.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $121.0 million through Dec 2025, down 38.36% year-over-year, with the annual reading at $121.0 million for FY2025, 38.36% down from the prior year.
  • Current Assets for Q4 2025 was $121.0 million at AC Immune, down from $196.3 million in the prior quarter.
  • The five-year high for Current Assets was $219.8 million in Q4 2021, with the low at $121.0 million in Q4 2025.
  • Average Current Assets over 5 years is $162.2 million, with a median of $141.1 million recorded in 2023.
  • The sharpest move saw Current Assets crashed 39.49% in 2022, then soared 39.15% in 2024.
  • Over 5 years, Current Assets stood at $219.8 million in 2021, then plummeted by 39.49% to $133.0 million in 2022, then rose by 6.11% to $141.1 million in 2023, then skyrocketed by 39.15% to $196.3 million in 2024, then tumbled by 38.36% to $121.0 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $121.0 million, $196.3 million, and $141.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.